ANNE MARIE SHAFTIC: Open Payments
NPI 1346348109 · TEANECK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,518 in 129 payments from 28 companies in 2025. Trend: 2023 $690 · 2024 $2,272 · 2025 $2,518
Food & beverage: $2,334Education: $184
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $285 |
| Janssen Biotech, Inc. | 12 | $279 |
| Eisai Inc. | 23 | $264 |
| Novartis Pharmaceuticals Corporation | 21 | $229 |
| TAIHO ONCOLOGY, INC. | 11 | $207 |
| ABBVIE INC. | 11 | $148 |
| Fennec Pharmaceuticals, Inc. | 2 | $142 |
| Astellas Pharma US Inc | 7 | $128 |
| Novo Nordisk Inc | 1 | $125 |
| Lilly USA, LLC | 1 | $117 |
Products named: Lenvima, KISQALI, LONSURF, RYBREVANT, Fyarro, LYNPARZA, Vyloy, Ozempic.
Industry payments across NJ — which companies pay providers there.
